The purpose of this bidding process is the future and eventual acquisition of medications, intended to meet the needs of the municipal health fund during the fiscal year 2026, aiming to guarantee the continuity and regularity of pharmaceutical assistance and health services provided to the population. This contract will be carried out through a price registration system (SRP), according to the provisions of Federal Law No. 14.133/2021, allowing the acquisition of the registered items.

The purpose of this bidding process is the future and eventual acquisition of medicines, intended to meet the needs of the Municipal Health Fund during the fiscal year 2026, aiming to guarantee the continuity and regularity of pharmaceutical assistance and health services provided to the population. This procurement will be carried out through a Price Registration System (SRP), in accordance with the provisions of Federal Law No. 14.133/2021, allowing the acquisition of registered items according to the administration's needs, observing the estimated quantities, registered prices, budgetary availability, and the conditions established in the Price Registration Record. Items: ACEBROFILINA 5 MG/ML, pediatric syrup (for children), bottle containing 120 mL, accompanied by a measuring cup or syringe, for oral use. Mucolytic and bronchodilator medication, indicated for the treatment of respiratory conditions with bronchial hypersecretion. Valid registration with ANVISA (Brazilian Health Regulatory Agency).; ACEBROFILINA 10 mg/mL, adult syrup, oral use, bottle (Fr.) containing 120 mL, accompanied by a measuring cup or syringe. Mucolytic and bronchodilator medication, indicated for the treatment of respiratory conditions with bronchial hypersecretion. Valid registration with ANVISA.; ACETYLSALICYLIC ACID 100 mg, tablet, oral use, solid pharmaceutical form, containing 100 mg of acetylsalicylic acid per pharmaceutical unit, packaged in the manufacturer's original packaging, with valid registration with ANVISA, expiration date according to current legislation and other specifications in accordance with the Brazilian Pharmacopoeia and applicable health regulations. Folic acid 5 mg, oral tablet, solid pharmaceutical form, containing 5 mg of folic acid per pharmaceutical unit, packaged in the manufacturer's original packaging, with valid registration with ANVISA (Brazilian Health Regulatory Agency), expiration date in accordance with current legislation and other specifications...